Stocks Health care BTMD
NASDAQ · Health carebiote Corp. (BTMD)
biote Corp. brought in $183.5M of revenue over the twelve months to June 30, 2026, down 7.8% from a year earlier. Net income was $5.9M, a net margin of 3.2%. Operating cash flow minus capital spending left $30.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $11.2M in cash against $125M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
Key facts about biote Corp.
- Net worth
- biote Corp. has a market value (market cap) of $38.1M at the latest share price, and shareholders' equity of -$65.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $192.2M (-2.5% year on year), with net income of $27M. Over the 12 months to June 30, 2026: revenue $183.5M, net income $5.9M.
- Cash flow
- In fiscal 2025 operations brought in $35.2M of cash; after $5M of capital spending, free cash flow was $30.2M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 7, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- biote Corp.'s next report was expected around November 4, 2026 and is not on file with the SEC yet.
What biote Corp. does
biote Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BTMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $192.2M | $27M | $0.74 | $30.2M |
| 2024 | $197.2M | $3.2M | $0.09 | $38.8M |
| 2023 | $185.4M | $3.3M | $0.13 | $26.5M |
| 2022 | $165M | -$969K | -$0.12 | -$9.5M |
| 2021 | $139.4M | $11.1M | n/a | $32.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BTMD ranks in Health care
Dividends
It paid out $1.7M in cash dividends, 6% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $1.7M | 6% |
| 2024 | n/a | $4.7M | 150% |
| 2023 | n/a | $8.7M | 262% |
| 2022 | n/a | $12.9M | n/a |
| 2021 | n/a | $11.4M | 103% |
Latest SEC filings
What biote Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026Passive stake changed SCHEDULE 13G/A
- September 1, 2026Passive stake changed SCHEDULE 13G/A
- August 28, 2026Passive stake (5% or more) SCHEDULE 13G
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 9.5% to $44.2M versus the same quarter last year; diluted EPS -$0.23 versus $0.10.
- August 5, 2026
- July 27, 2026Passive stake changed SCHEDULE 13G/A
- June 17, 2026
- June 2, 2026
- May 18, 2026
- May 13, 2026Passive stake changed SCHEDULE 13G/A
What is BTMD worth? A DCF from its reported cash flow
Insider trades
What the people running biote Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 11, 2026 | Beer Marc DExecutive Chairman, Director | Bought | 16,000 | $24.8K |
| August 10, 2026 | Beer Marc DExecutive Chairman, Director | Bought | 115,950 | $177.4K |
| May 12, 2026 | Morris Debra LDirector | Exercised options | 21,407 | - |
Who owns BTMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Roystone Management Holdings LLC13D, may seek influence with 3 related filers | 14% | June 12, 2025 |
| Agarwal Amit Mohan13G, passive | 8.4% | September 18, 2026 |
| Bandera Partners LLC13G, passive with 2 related filers | 6.4% | May 13, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 72 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| 325 Capital LLC | 4,548,127 | 0 |
| Bandera Partners LLC | 2,065,482 | 0 |
| Vanguard Capital Management LLC | 1,102,753 | -11,102 |
| Millennium Management LLC | 436,088 | new |
| Dimensional Fund Advisors LP | 431,962 | -111,532 |
| BlackRock, Inc. | 365,945 | -1,373,299 |
| Citadel Advisors LLC | 301,310 | new |
| Rice Hall James & Associates, LLC | 262,842 | +12,823 |
| Geode Capital Management, LLC | 260,488 | -355,174 |
| Jane Street Group, LLC | 253,313 | new |
| Aqr Capital Management LLC | 251,619 | +197,960 |
| UBS Group AG | 244,224 | +218,496 |
| Renaissance Technologies LLC | 229,994 | -35,922 |
| Goldman Sachs Group Inc | 215,384 | +114,775 |
| Marshall Wace, Llp | 168,611 | new |
| Morgan Stanley | 153,907 | -34,293 |
| Vanguard Fiduciary Trust Co | 142,964 | -14,177 |
| State Street Corp | 112,244 | -534,710 |
| Jones Financial Companies Lllp | 111,605 | +64,877 |
| Susquehanna International Group, Llp | 103,307 | +92,375 |
Insiders
2 insiders reported holding 311,306 shares in total, about $330K at the last price.
| Holder | Shares |
|---|---|
| Beer Marc DExecutive Chairman, Director | 239,744 |
| Morris Debra LDirector | 71,562 |
Questions about BTMD
What does biote Corp. do?
biote Corp. is a company in the Health care sector, listed on NASDAQ as BTMD. Its shares trade on NASDAQ under the ticker BTMD.
What is biote Corp.'s net worth?
biote Corp. has a market value (market cap) of $38.1M at the latest share price, and shareholders' equity of -$65.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is biote Corp. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $5.9M on revenue of $183.5M, a net margin of 3.2%.
How much revenue does biote Corp. make?
Over the twelve months to June 30, 2026 biote Corp. reported revenue of $183.5M. That is 7.8% less than a year earlier.
When did biote Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from September 18, 2026.
When is biote Corp.'s next earnings report?
biote Corp.'s next report was expected around November 4, 2026 and is not on file with the SEC yet.
Similar companies
Compare BTMD with
Follow BTMD
Get an email when biote Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values biote Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.